Results 171 to 180 of about 20,315,662 (409)
Laboratory Investigation of Tomography-Controlled Continuous Steel Casting. [PDF]
Sensors (Basel), 2022 Glavinić I +10 more
europepmc +1 more source
Molecular Oncology, EarlyView.Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo +11 more
wiley +1 more source
Alternative Fillers in Asphalt Concrete Mixtures: Laboratory Investigation and Machine Learning Modeling towards Mechanical Performance Prediction. [PDF]
Materials (Basel), 2023 Tiwari N +3 more
europepmc +1 more source
Use of Modern Laboratory Aids in the Investigation of a Typhoid Fever Outbreak
, 1943 Edward R. Schlesinger
openalex +2 more sources
Molecular Oncology, EarlyView.In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source
An Investigation of Voluntary Discovery and Disclosure of Environmental Violations Using Laboratory Experiments [PDF]
This paper uses laboratory experiments to test individual responses to policies that seek to encourage firms to voluntarily discover and disclose violations of environmental standards. We find that while it is possible to motivate a significant number of
James J. Murphy, John K. Stranlund
core
Efficiency and complications in root canal retreatment using nickel titanium rotary file with continuous rotation, reciprocating, or adaptive motion in curved root canals: a laboratory investigation. [PDF]
BMC Oral Health, 2023 Tantiwanichpun B, Kulvitit S.
europepmc +1 more source
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
Molecular Oncology, EarlyView.DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez +5 more
wiley +1 more source